Peptide record

TPDB48383

ACE inhibitors Antihypertensive standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB48383
ACE inhibitors Antihypertensive
Cardiometabolic peptides
Peptipedia
standard
No
A 21-aa standard-residue multi-activity (ACE inhibitors and Antihypertensive) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
ISFYQQPEENACQQQYLNAQQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C109H160N30O38S1
RDGHKMTWV
Q
2530.71
3.13
0
2
7
-2
2.46
-1.252
46.67
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
2980
1.18
13
Residue Composition
number
2
A
0
R
2
N
0
D
1
C
2
E
7
Q
0
G
0
H
1
I
1
L
0
K
0
M
1
F
1
P
1
S
0
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 2 D: 0 C: 1 E: 2 Q: 7 G: 0 H: 0 I: 1 L: 1 K: 0 M: 0 F: 1 P: 1 S: 1 T: 0 W: 0 Y: 2 V: 0
Chemical Descriptors
21 reviewed residue count
C109H160N30O38S1 sequence-only estimate (linear, free termini)
2530.71 sequence-only estimate (linear, free termini)
3.13 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
2.46 sequence-only estimate (linear, free termini)
-1.252 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA